EKGCX | RSEBX | EKGCX / RSEBX | |
Total Expense Ratio | 2.22 | 1.45 | 153% |
Annual Report Gross Expense Ratio | 2.30 | 1.45 | 159% |
Fund Existence | 33 years | 11 years | - |
Gain YTD | 1.509 | 9.389 | 16% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 119M | 80.3B | 0% |
Annual Yield % from dividends | 0.00 | 0.23 | - |
Returns for 1 year | -2.66 | 9.79 | -27% |
Returns for 3 years | -5.74 | 20.18 | -28% |
Returns for 5 years | -17.39 | 12.50 | -139% |
Returns for 10 years | -29.01 | 44.85 | -65% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PBE | 67.81 | 0.63 | +0.93% |
Invesco Biotechnology & Genome ETF | |||
SZOXF | 7.01 | N/A | N/A |
Deutsche Bank AG (London Branch) | |||
TDTF | 24.14 | -0.03 | -0.12% |
FlexShares iBoxx 5Yr Target Dur TIPS ETF | |||
ITOT | 140.57 | -0.33 | -0.23% |
iShares Core S&P Total US Stock Mkt ETF | |||
KNGZ | 34.61 | -0.11 | -0.32% |
FirstTrust S&P500 DvrsDiv AristocratsETF |